Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 901–1,000 of 1,000
Treatment and Recovery for the Family
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0011
How Substance Problems Affect the Family Unit
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0009
Recovery for Individual Family Members
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0012
Recovery from a Substance Use Disorder
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0006
Relapse After a Period of Recovery
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0007
Helping Children Affected by a Parent’s Substance Use Disorder
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0013
How Substance Problems Affect Individual Family Members
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.003.0010
Assessment of the consequences of gestational SSRI antidepressant exposure in the rat
DeSanctis, N. A. (2019) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16852
What is the best management for pregnant women with opioid addiction?
Anderson, C. E., & Onders, A. (2019) · Evidence-Based Practice · doi:10.1097/ebp.0000000000000166
Shrestha, S. (2019) · UNM’s Digital Repository (University of New Mexico)
Özmen, H., Aydınlı, B., ÇİTİLCİOĞLU, U. S., & Yücel, A. (2020) · Journal of Anesthesiology and Reanimation Specialists’ Society · doi:10.5222/jarss.2020.41275
Peripartum pain management of women on medication-assisted therapy: A systematic review
Kim, I., Nguyen, T.-A. T., & Bicket, M. (2020) · Journal of Obstetric Anaesthesia and Critical Care · doi:10.4103/joacc.joacc_45_19
Medication Assisted Treatment for Opioid Use Disorder during Pregnancy
Leeman, L. M., & Starer, J. (2018)
Perinatal Outcomes in a Cohort of Offspring Exposed to Methadone Maintenance Therapy (MMT) in Utero
Pylypjuk, C. L., & Romina, L. (2020) · Clinical Pediatrics and Research · doi:10.36959/395/510
Drugs to Treat Substance Use Disorders
Sinclair, J., & Peters, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.017
Batra, K. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/19412019
Beausang, J. K., & Cooper, S. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.034
Surakka, V.-M. (2011) · UEF eRepo (University of Eastern Finland)
The Pregnancy Recovery Support Program:
Zadzielski, E., & Horton, T. L. (2018) · Delaware Journal of Public Health · doi:10.32481/djph.2018.05.010
Johnson, E., Momand, A. S., & Jones, H. E. (2021) · Oxford University Press eBooks · doi:10.1093/acrefore/9780190632366.013.187
Self-citationOverview and Summary: Substance Use Disorders and Related Concerns: Perspectives from Nurses
Fathi, J. T. (2020) · OJIN The Online Journal of Issues in Nursing · doi:10.3912/ojin.vol25no03manos
Prenatal Drug Use: Neonatal Effects and the Neonatal Withdrawal Syndrome
Ostrea, E. M., Cortez, J. M., Alviedo, N. J. B., Bañadera, F. D. P., Jesus, L. C. D., & Cheng, C. T. (2016) · doi:10.9954/gb104
Seligman, N. S. (2011) · Series in maternal-fetal medicine · doi:10.3109/9781841848235.023
Gutierrez, R., Bicocca, M. J., Opara, G., Gupta, M., Bartal, M. F., Chauhan, S. P., & Wagner, S. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2022.100142
(2012) · Wiley eBooks · doi:10.1002/9781118105955.ch28
Anaya, H., & Betz, A. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.016
Vrees, R. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.025
Jackson, J. R., & Decesare, J. Z. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.028
Standifer, R., & Garrison, E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.003
Newman, L., & Frey, H. A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.005
Welt, S. I. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.017
Canela, C. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.011
Tsaltas, T. T. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.008
Beasley, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.020
Rigby, F. B. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.023
Ainsworth, S. B. (2014) · Wiley eBooks · doi:10.1002/9781118819494.ch15
(2011) · Wiley eBooks · doi:10.1002/9781118101056.refs
Campbell, J. P., & Plaat, F. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.013
Williford, A. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.022
OLSEN, M. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.021
Garrison, E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.002
OLSEN, M. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.001
Churchill, D., & Moussa, M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.030
Jilani, S. M., Jones, H. E., Jansson, L. M., Terplan, M., & Davis, J. M. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.04.022
Self-citation(2022) · Journal of Addiction Research · doi:10.33140/jar.06.01.04
Coyle, M. G. (2012) · Springer eBooks · doi:10.1007/978-3-642-02202-9_34
Self-citationSpezielle Arzneimitteltherapie in der Stillzeit
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-21203-1.10004-4
Brown, M. S. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.47
Calhoun, B. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-26710-4_6
Cleary, B., & Murphy, D. J. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.015
Ainsworth, S. B. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198840787.003.0025
Opioids and Opioid Use Disorder (OUD) in Pregnancy
Mallick‐Searle, T. (2022) · Springer eBooks · doi:10.1007/978-3-031-06322-0_3
Khalid, A., Rashid, A., Hina, S., Tahir, K., Karim, S. A., & Rana, M. Z. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22168533
Tobacyk, J., & Brents, L. K. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2183469
Soares, M. E., & de Sales, E. R. (2023) · Educação Matemática em Revista · doi:10.37001/emr.v28i78.2720
Supplementary material A: Commentaries
Ainsworth, S. B. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198840787.005.0001
Intrauterine Drug Exposure: Fetal and Postnatal Effects
Baer, G., Singh, R., & Davis, J. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00011-8
Treating Opioid Use During Pregnancy and Postpartum Life Phases
Jones, H. E. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.28
Self-citationSoni, A., Bullinger, L. R., Andrews, C. M., Abraham, A. J., & Simon, K. I. (2023) · Contemporary Economic Policy · doi:10.1111/coep.12623
Mason, I., Abdelwahab, M., Stiles, A., Wu, J., Venkatesh, K. K., & Rood, K. M. (2023) · American Journal of Perinatology · doi:10.1055/a-2200-3187
Flaherty, L. T. (2023) · Springer eBooks · doi:10.1007/978-3-031-42502-8_9
Opioid Use Disorder: Approach to Intrapartum and Postpartum Management
Sudhof, L. S., & Bernstein, S. N. (2023) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-023-00371-w
Alcohol and Substance Use Disorder
Kendle, A. M., & Običan, S. G. (2023) · Wiley eBooks · doi:10.1002/9781119636540.ch3
Treating Neonatal Abstinence Syndrome in the Newborn
Maxwell, J. R., Brooks, S. S., Lewis, T. R., Newville, J., McLemore, G. L., & Gauda, E. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-69415-5.00055-2
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Maisel, B. A., Adeniyi-Jones, S. C., Selvage, E., Ng, S., Kraft, W. K., & Chervoneva, I. (2024) · Journal of Perinatology · doi:10.1038/s41372-024-01895-6
Save a Life, Initiate Buprenorphine: Emergency Department Buprenorphine Administration
Kruse, M., & da Silva, J. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197635513.003.0013
Effects of perinatal opioid exposure, volume II
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4799-1
(2024) · Oxford University Press eBooks · doi:10.1093/med/9780192844088.003.0024
Pharmacological Treatment of Substance Use Disorders
Srivastava, A. B., LEVIN, F. R., & Nunes, E. V. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_140
Passive Addiction and Teratogenic Effects
McPherson, C. C., Inder, T. E., & Volpe, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10513-5.00042-5
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.002.0003
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.002.0005
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.002.0007
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.002.0006
Daley, D. C., & Douaihy, A. B. (2019) · Oxford University Press eBooks · doi:10.1093/med-psych/9780190926632.005.0001
Chapter 18. Substance Use Disorders
(2023) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375264.lg18
Chapter 12. Substance Use Disorders in Pregnancy
(2023) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379989.lg12
Madde Kullanım Bozukluğunda Ebelik Yaklaşımı
Başyiğit, F., Bulut, E., Bay, H., Çelik, B., Yalvaç, S., Sönmez, T., Ada, G., Bülez, A., Erdī, G., Yıldırım, A. D., et al. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3457
Overview of Amplitude Integrated Electroencephalography in Neonatal Opioid Withdrawal Syndrome
Kaulas, H., & Mathur, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-32035-4_139-1
Addictions and Substance Misuse
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg004.pub2
Emergency Approach to Buprenorphine and Methadone in Pregnancy
Rahman, M. (2025) · National Journal of Emergency Medicine SEMI · doi:10.5005/njem-11015-0063
Zielenbach, M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009413787.094
Ahmed, F. Z., Golan, O. K., Totaram, R., Akil, S., Fatima-Hashani, N., Whitaker, D. J., Pigott, T., & Andraka‐Christou, B. (2025) · Health Communication · doi:10.1080/10410236.2025.2521716
Substance use disorder in pregnancy: A review
Cherniak, V., Turner, S., & Wyne, A. (2025) · Canadian Journal of General Internal Medicine · doi:10.3138/cjgim.2024.0035
Duration of monitoring for withdrawal in neonates exposed to in-utero opioids
Tiranchi, A. S., El‐Metwally, D., & Mark, K. (2025) · Journal of Neonatal-Perinatal Medicine · doi:10.1177/19345798251365202
Overview of Amplitude Integrated Electroencephalography in Neonatal Opioid Withdrawal Syndrome
Kaulas, H., & Mathur, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_139
Orsolini, L., Francesconi, G., Volgare, R., Schifano, F., & Volpe, U. (2025) · Springer eBooks · doi:10.1007/978-3-031-99720-4_22
Kaneko-Tarui, T., Carasi-Schwartz, F., Singh, K., Gildawie, K. R., Vassoler, F. M., Byrnes, E. M., & Yen, E. (2026) · Scientific Reports · doi:10.1038/s41598-026-49873-6
Thakrar, A. P., & Rastegar, D. A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197796207.003.0006
Clinical Pharmacological Research Aiming to Optimize Therapeutic Strategies in Specific Populations
Tanaka, R. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.25-00113
Zerbo, E. A., & Aggarwal, R. (2016) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370726.lg11
Chapter 10. Medication-Assisted Treatment for Opioid Use Disorder
Marino, L. A., Oreck, S., & Kolander, S. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372140.lg10
Chapter 5. Clinical Use of Buprenorphine
Restrepo, R., & Levounis, P. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371709.lg05
Chapter 14. Women’s Health and Pregnancy
LaRose, A. T., & Jones, H. E. (2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371709.lg14
Self-citationการพัฒนารูปแบบการการดูแลระยะหลังคลอดสำหรับหญิงตั้งครรภ์ที่ใช้ยาบ้าใน จังหวัดกาฬสินธุ์
ทุมวงศ์, ณ. (2025) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร · doi:10.64960/srimedj.v40i5.267588
Effect of Selective Serotonin Receptor Inhibitors on Neonatal Opioid Withdrawal Syndrome Outcomes
Anbalagan, S., Anderson, V. A., Favara, M. T., Stark, D., Carola, D. L., Solarin, K. O., Adeniyi-Jones, S. C., & Aghai, Z. H. (2025) · Pediatrics Open Science · doi:10.1542/pedsos.2025-000788
Pharmacologic and Clinical Considerations of Buprenorphine
Kaye, A. D., Serio, M. A., Dethloff, D. R., Ahmadzadeh, S., Shekoohi, S., & Kaye, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-032-07407-2_14
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.